Gene Techno Science Co Ltd (4584.T)

4584.T

About

Gene Techno Science Co., Ltd. is a Japan-based company mainly engaged in the research and development, manufacture and sale of biopharmaceuticals. The Company operates in two business segments. The Biosimilar segment is engaged in the research, development, manufacture and sale of biosimilars, include granulocyte-colony... (more)

Buy/Sell

No analyst recommendations are available for 4584.T.

» Analyst Consensus

Overall

Beta:	--
Market Cap (Mil.):	¥17,460.43
Shares Outstanding (Mil.):	2.08
Dividend:	--
Yield (%):	--

Financials

	4584.T	Industry	Sector
P/E (TTM):	--	54.65	35.85
EPS (TTM):	-244.36	--	--
ROI:	--	0.83	18.76
ROE:	--	1.79	19.57

Latest News about 4584.T

» More 4584.T News

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Wright Investors Service Comprehensive Report for Gene Techno Science Co Ltd Provider: Wright Reports	$368.00 Buy
Gene Techno Science Co., Ltd. (4584) - Financial Analysis Review Provider: GlobalData	$125.00 Buy
Gene Techno Science Co., Ltd. (4584) - Financial Analysis Review Provider: GlobalData	$125.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.